P-203: EXCALIBER: a phase 3 study comparing iberdomide, daratumumab, and dexamethasone (IberDd) with daratumumab, bortezomib, and dexamethasone (DVd) in patients with relapsed or refractory multiple myeloma
作者
Sagar Lonial,Jesús G. Berdeja,Meletios Athanasios Dimopoulos,Sundar Jagannath,Stefan Tobias Knop,Hang Quach,Paula Rodríguez‐Otero,Paul Gerard Guy Richardson,April Sorrell,Min Chen,Elisabeth Kueenburg,Tuong Vi Nguyen,Kevin Hong,Teresa Peluso,Niels W.C.J. van de Donk